186 related articles for article (PubMed ID: 18565325)
1. ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor.
Harada N; Ohmori Y; Yamaji R; Higashimura Y; Okamoto K; Isohashi F; Nakano Y; Inui H
Biochem Biophys Res Commun; 2008 Aug; 373(3):373-7. PubMed ID: 18565325
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
[TBL] [Abstract][Full Text] [Related]
3. RanBP10 acts as a novel coactivator for the androgen receptor.
Harada N; Yokoyama T; Yamaji R; Nakano Y; Inui H
Biochem Biophys Res Commun; 2008 Mar; 368(1):121-5. PubMed ID: 18222118
[TBL] [Abstract][Full Text] [Related]
4. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
[TBL] [Abstract][Full Text] [Related]
5. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
[TBL] [Abstract][Full Text] [Related]
7. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Heitzer MD; DeFranco DB
Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
[TBL] [Abstract][Full Text] [Related]
8. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
Dehm SM; Regan KM; Schmidt LJ; Tindall DJ
Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941
[TBL] [Abstract][Full Text] [Related]
9. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
10. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.
Nishimura K; Ting HJ; Harada Y; Tokizane T; Nonomura N; Kang HY; Chang HC; Yeh S; Miyamoto H; Shin M; Aozasa K; Okuyama A; Chang C
Cancer Res; 2003 Aug; 63(16):4888-94. PubMed ID: 12941811
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions.
Yang CS; Xin HW; Kelley JB; Spencer A; Brautigan DL; Paschal BM
Mol Cell Biol; 2007 May; 27(9):3390-404. PubMed ID: 17325038
[TBL] [Abstract][Full Text] [Related]
12. In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line.
Chang HC; Chen SC; Chen J; Hsieh JT
J Formos Med Assoc; 2005 Sep; 104(9):652-8. PubMed ID: 16276440
[TBL] [Abstract][Full Text] [Related]
13. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
[TBL] [Abstract][Full Text] [Related]
14. Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation.
Park SY; Yu X; Ip C; Mohler JL; Bogner PN; Park YM
Cancer Res; 2007 Oct; 67(19):9294-303. PubMed ID: 17909037
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer.
Li P; Yu X; Ge K; Melamed J; Roeder RG; Wang Z
Am J Pathol; 2002 Oct; 161(4):1467-74. PubMed ID: 12368219
[TBL] [Abstract][Full Text] [Related]
16. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
17. GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor.
Shen HC; Buchanan G; Butler LM; Prescott J; Henderson M; Tilley WD; Coetzee GA
Biol Chem; 2005 Jan; 386(1):69-74. PubMed ID: 15843149
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.
Chiu CM; Yeh SH; Chen PJ; Kuo TJ; Chang CJ; Chen PJ; Yang WJ; Chen DS
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2571-8. PubMed ID: 17259306
[TBL] [Abstract][Full Text] [Related]
20. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
Ghadessy FJ; Lim J; Abdullah AA; Panet-Raymond V; Choo CK; Lumbroso R; Tut TG; Gottlieb B; Pinsky L; Trifiro MA; Yong EL
J Clin Invest; 1999 Jun; 103(11):1517-25. PubMed ID: 10359561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
